AAAAAA
Results:
1-7
|
Results: 7
Authors:
FRANCASTEL C
AUGERYBOURGET Y
PRENANT M
WALTERS M
MARTIN DIK
ROBERTLEZENES J
Citation: C. Francastel et al., C-JUN INHIBITS NF-E2 TRANSCRIPTIONAL ACTIVITY IN ASSOCIATION WITH P18MAF IN FRIEND-ERYTHROLEUKEMIA CELLS/, Oncogene, 14(7), 1997, pp. 873-877
Authors:
LENAOUR F
FRANCASTEL C
PRENANT M
LANTZ O
BOUCHEIX C
RUBINSTEIN E
Citation: F. Lenaour et al., UP-REGULATION OF CD9 EXPRESSION DURING TPA TREATMENT OF K562 CELLS, Leukemia, 11(8), 1997, pp. 1290-1297
Authors:
FRANCASTEL C
POINDESSOUSJAZAT V
AUGERYBOURGET Y
ROBERTLEZENES J
Citation: C. Francastel et al., NF-E2P18 MAFK IS REQUIRED IN DMSO-INDUCED DIFFERENTIATION OF FRIEND-ERYTHROLEUKEMIA CELLS BY ENHANCING NF-E2 ACTIVITY/, Leukemia, 11(2), 1997, pp. 273-280
Authors:
LENAOUR F
PRENANT M
FRANCASTEL C
RUBINSTEIN E
UZAN G
BOUCHEIX C
Citation: F. Lenaour et al., TRANSCRIPTIONAL REGULATION OF THE HUMAN CD9 GENE - CHARACTERIZATION OF THE 5'-FLANKING REGION, Oncogene, 13(3), 1996, pp. 481-486
Authors:
FRANCASTEL C
WALTERS MC
MARTIN DIK
ROBERTLEZENES J
Citation: C. Francastel et al., C-JUN IS A NEGATIVE REGULATOR OF FRIEND ERYTHROID-DIFFERENTIATION BY FORMING HETERODIMERS WITH P18 MAF THAT ARE UNABLE TO ACTIVATE TRANSCRIPTION FROM NF-E2 SITES/, Blood, 86(10), 1995, pp. 48-48
Authors:
FRANCASTEL C
GROISMAN R
PFARR CM
ROBERTLEZENES J
Citation: C. Francastel et al., ANTISENSE C-JUN OVERCOMES A DIFFERENTIATION BLOCK IN A MURINE ERYTHROLEUKEMIA CELL-LINE, Oncogene, 9(7), 1994, pp. 1957-1964
Authors:
FRANCASTEL C
WALTERS MC
MARTIN DIK
ROBERTLEZENES J
Citation: C. Francastel et al., ANTISENSE C-JUN INHIBITS TRANSCRIPTION FROM AP-1 TRE SITE BUT ACTIVATES TRANSCRIPTION FROM NF-E2 AP-1 SITE IN ERYTHROID-CELLS, Blood, 84(10), 1994, pp. 10000421-10000421
Risultati:
1-7
|